Physician profile
Lucy Wang Wei
NPI 1235684366
$1,560.59
in general payments reported to CMS, 2019-2025
15 companies · $567 in 2025
The $567 reported for 2025 was more than what 82% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $359 · 2022: $125 · 2024: $510 · 2025: $567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,077.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,076.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $283.49 | 2021-2024 | |
| Kerecis Limited | $256.53 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Polynovo North America LLC | $194.44 | 2025 | Novosorb Btm |
| W. L. Gore & Associates, INC. | $160.31 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Janssen Scientific Affairs, LLC | $125.00 | 2022 | |
| Motiva USA, LLC | $125.00 | 2025 | |
| Davol INC. | $97.46 | 2025 | Phasix Mesh |
| Janssen Biotech, INC. | $86.13 | 2021 | |
| Lilly USA, LLC | $70.02 | 2021 | |
| Vyne Pharmaceuticals INC. | $53.00 | 2021 | |
| Sun Pharmaceutical Industries INC. | $34.45 | 2021 | |
| Pfizer INC. | $19.59 | 2021 | |
| Genzyme Corporation | $18.99 | 2021 | |
| Sanofi-Aventis U.S. LLC | $18.29 | 2021 | |
| Novartis Pharmaceuticals Corporation | $17.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucy Wei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.